ICON8 stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer.
Authors
James, EHook, J
Stenning, S
Cook, A
Coyle, C
Petrie, J
Kaplan, R
McNeish, I
Perren, T
Naik, R
Banerjee, S
Ledermann, J
Clamp, Andrew R
Affiliation
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology-UCL, LondonIssue Date
2016-10-01
Metadata
Show full item recordCitation
ICON8 stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer. 2016, 27(suppl 6):861P Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw374.08Additional Links
https://academic.oup.com/annonc/article/2799597/ICON8Type
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw374.08